PatSnap

AI Centrality

How much of the product is actually AI. Whether the machine learning is the mechanism the buyer is paying for or a feature layered onto conventional software, and whether the vendor is specific about which is which.

A data platform that existed for over a decade before the models, with a substantial AI layer built on top of it. Founded 2007, and the asset underneath is the corpus: more than 2 billion structured data points and over 210 million patent, science and technology records with search, landscaping, dashboards and analytics that predate generative AI and function without it. Eureka is described by the vendor itself as a capability layer rather than a separate platform, which is an accurate self assessment and is credited as such. The AI layer is genuinely substantial rather than decorative, spanning domain specific agents for prior art, freedom to operate, drafting, translation and life sciences work, and the vendor describes a four stage data pipeline built to feed it. Graded B on the same basis as Relativity, Everlaw and Lexis+ AI: a mature platform hosts the model layer rather than depending on it. Remove the models and PatSnap remains a working patent analytics business. This is the first record in ip-and-patents below A on this axis, and the reason is age rather than weakness.

Citation Accuracy and Hallucination Disclosure

Whether the vendor publishes measured accuracy on citations and assertions, grounds output to primary sources, and says plainly what its system does when it does not know. Legal has a documented public record of fabricated citations reaching filed briefs, so an untested claim of accuracy is not evidence.

THE FIRST PUBLISHED BENCHMARK WITH A STATED METHODOLOGY AND A NAMED COMPARATOR IN 51 RECORDS. PatentBench is published as a benchmark built for real patent work, stated to measure specific tasks against structured data, legal context and source linked evidence, with a full methodology the vendor links rather than summarises. Published results: a 77 percent hit rate on design freedom to operate, and a claim of being 83 times more accurate than ChatGPT on that measure. Naming the comparator and the task is what separates this from the unfalsifiable claims elsewhere on this index, because a reader can locate the methodology and disagree with it. Grounding is described architecturally as well: retrieval augmented generation over a governed corpus, a four stage pipeline the vendor states reduces hallucinations through governance at each stage, and source linked evidence as a stated property of the benchmark. Graded A because this axis rewards verifiable evidence checkable by an outsider without contacting the vendor, and a published methodology with a stated result meets it. Held short of perfection and recorded plainly: the benchmark is the vendor's own rather than independent, the 83 times figure is a ratio against a general purpose chatbot on a task it was never built for, which flatters the comparison, and the methodology page itself was not read in this pass, making this a correction candidate in both directions.

Autonomy and Oversight Model

What the system decides on its own, what a lawyer must approve, and whether the vendor documents where the review point sits. A tool that drafts under review and a tool that files without one are different products and different risks.

Agent language is used extensively and no oversight model is published. The platform is described as agentic across IP and life sciences, with named agents including an FTO Agent, a Lead Compound analyser, an Antibody Target Predictor and a Markush Claim Drafting agent, and a published customer account describes completing infringement analysis for new products in hours rather than weeks. Data governance is described at each stage of the pipeline, which is governance of inputs rather than of agent behaviour. Nothing published states what an agent may complete without human review, whether any output can be relied on without verification, what confidence signal accompanies an agent result, or where a human checkpoint sits in an agentic workflow that runs from query to report. The gap matters because the outputs described are decision grade: a freedom to operate assessment that clears a product for launch, and a novelty judgement that decides whether a molecule is pursued. Checked the Eureka product pages, the life sciences landing page, the home page and the Open Platform material on 29 Aug 2026.

Operational and Outcome Evidence

Named, dated evidence that the product works in production at real firms or legal departments. Case studies with figures and identified customers count. Unattributed testimonials and launch announcements do not.

Named customers of the highest recognisability, a named executive, and independent third party presence, all dated and checkable. Named customers include NASA, Tesla, Vodafone, MIT and General Electric, reported in independent trade coverage rather than only on vendor surfaces, plus NCH Corporation with a named executive, Michael Schuster, VP of Product Development and Innovation, quoted by name and title on vendor material. Corporate history is a matter of public record: founded 2007, unicorn valuation reached in 2021 following a $300m Series E led by SoftBank Vision Fund 2 and Tencent, with Jeffrey Tiong named as chief executive. Independent evidence extends beyond a press release: a Gartner Peer Insights listing, a SoftwareOne marketplace listing, and a hands on product review by a named trade publication that obtained a trial and published its assessment. An outsider can verify the company, the customers, the funding and the product without contacting the vendor. Held short of perfection because outcome claims carry no methodology, being productivity boosted by up to 60 percent and workflows 90 percent faster, and one customer quote describing hundreds of thousands of dollars saved is not attributed to a named organisation.

Privilege and Confidentiality Posture

How client confidences are handled: attorney client privilege and work product treatment, segregation of one client matter from another, whether client data trains any model, and what the vendor commits to in writing rather than in marketing.

General enterprise confidentiality is evidenced and the legal professional dimension is absent, and the buyer profile explains why without excusing it. Published: strict data isolation, ISO certified security policies, encryption in transit and at rest, consent management, GDPR and CCPA compliance, and a positioning as a privacy first partner for enterprises. Those are real controls covering the confidential research and portfolio material customers upload. What does not appear anywhere: attorney client privilege, work product, or any acknowledgement that a law firm user's material carries professional obligations distinct from a corporate research team's. The distinction from category peers is instructive rather than incidental. Patlytics and Solve Intelligence sell primarily to patent practitioners and both reached A here by engaging the professional rules; PatSnap sells across research and development, strategy, life sciences and legal, and addresses confidentiality as an enterprise data question throughout. That is coherent for its market and it leaves the practitioner question unanswered. Checked the trust centre material, the home page, the Eureka pages and the security statements on 29 Aug 2026.

UPL and Professional Responsibility Posture

Whether the vendor is clear that it supplies a tool rather than legal advice, who its audience is, and how it addresses unauthorized practice of law, competence and supervision duties, and jurisdiction limits. ABA Formal Opinion 512 is the reference point.

Not located. The platform generates freedom to operate assessments, novelty and design patent risk analyses, and drafts patent claims including Markush structures, all of which are outputs a practitioner signs off or a business relies on, and the customer accounts published describe non lawyers in research and development using them for risk management decisions. Nothing published addresses whether output constitutes legal advice, what the role of qualified counsel is where an engineer or a chemist runs a freedom to operate agent directly, or any professional conduct framework. The question is arguably more live for this vendor than for its category peers precisely because its named buyers include scientists and engineers rather than only attorneys. Checked the home page, the Eureka pages, the life sciences landing page, the trust centre material and the site navigation on 29 Aug 2026.

AI Governance and Bias Disclosure

Published governance over model behaviour: who owns it inside the vendor, what is tested before release, and what is disclosed about disparate output across matter types, parties, or populations.

Data governance is described in operational detail and model governance is not. The vendor publishes that a four stage pipeline processes over 2 billion data points across 20 specialised domains with rigorous governance at every stage, stating this is what reduces hallucinations and improves output reliability, and names its retrieval architecture. PatentBench, graded on the Citation Accuracy axis, is a published evaluation instrument and its existence is evidence that measurement happens. What is absent is governance of the models themselves: no AI policy, no model card, no bias or fairness testing, no accuracy monitoring beyond the benchmark, no drift statement, no named governance body, no ISO 42001 and no EU AI Act positioning. The distinction being drawn is between governing the corpus and governing the system, and this vendor documents the first thoroughly and the second not at all. Compare Patlytics at B with an ISO 42001 certificate, and Solve Intelligence at B with a published continuous evaluation process and an EU AI Act self classification.

AI Safety and Data Stewardship

Retention, deletion, access control, and what happens to prompts and documents after they are processed. Whether the vendor states its subprocessors and its incident practice, or leaves the buyer to assume.

Isolation and compliance are stated and the training question is unanswered. Published: strict data isolation, ISO certified security policies, encryption in transit and at rest with named protocol and cipher, GDPR and CCPA compliance with stated consent management, and a self description as privacy first. Consent management is a genuine element and few records on this index name it. What was not located is any statement on whether customer uploaded documents, search histories, proprietary formulations or research materials are used to train or improve the domain models, any retention period, or any deletion right. The gap is material for this product because customers upload their own novel compounds, formulations and unpublished technical material into an analysis platform, which is competitively sensitive in a way patent search over public data is not. Compare Solve Intelligence at A and DeepIP at B in this category, both of which state a retention or training position plainly. Checked the trust centre material, the home page, the Eureka pages and the security statements on 29 Aug 2026.

AI Liability and Recourse

What the vendor stands behind contractually when its output is wrong. Indemnities, caps, carve outs, insurance, and whether any of it is published or only reachable through a negotiated agreement.

No published position located. Nothing was found on liability for AI output, warranty, service levels or remedy. The exposure here is unusual on this index because the consequential outputs are business decisions rather than filings: a published customer account describes the FTO Agent transforming risk management by completing infringement analysis in hours, and another describes lead compound screening acting as the first gate in a research and development process, so a false clearance sends a product to market and a false negative on novelty kills a viable molecule. The vendor publishes a 77 percent hit rate on design freedom to operate, which by its own arithmetic means roughly one in four is missed, and no published position addresses who carries that. Checked the home page, the Eureka pages, the life sciences landing page, the trust centre material and the site navigation on 29 Aug 2026.

Practice Systems Integration Depth

How deeply the product reaches into the systems legal work already lives in: document management such as iManage and NetDocuments, Word and Outlook, contract lifecycle management, matter management, e-billing, and court filing systems.

THE MOST COMPLETE INTEGRATION DISCLOSURE ON THE INDEX. The Patsnap Open Platform is a dedicated developer product, not a connector list, offering four distinct integration surfaces: REST APIs, MCP servers, UI widgets and agent skills, with a published Developer Center and documentation. Coverage is enumerated rather than claimed: more than 20 patent APIs, more than 25 corporate APIs and more than 16 infringement APIs. The MCP server offering is the notable element, since it exposes the corpus and its agents as tools to external AI systems, and the vendor names the frameworks it targets including LangChain, AutoGen and function calling workflows, which is integration aimed at how AI systems are actually assembled in 2026. Agent skills as a published surface goes further still. A buyer can obtain an API key from the site. Graded A because a developer can assess, obtain and build against this without contacting sales, which is the top of this axis, and because the surfaces are enumerated with counts rather than asserted. Held short of perfection because no named IP management or docketing system integration was located, which is the one thing a prosecution practice would ask for and which DeepIP states.

Deployment Model and Data Residency

Where the software runs and where the data sits. Multi tenant cloud, single tenant, private deployment, on premises, and whether region of residence is a published option or an enterprise conversation.

Nothing located. No hosting provider is named, no region or data residency commitment is published, and no single tenant, dedicated or on premise option is described. The absence is more consequential for this vendor than for most on the index: the company is headquartered in Singapore with named investors including SoftBank and Tencent and serves customers including NASA, MIT and General Electric, so the jurisdiction in which research material and unpublished technical data is processed is a question those customers' own compliance functions would ask directly, and it is unanswered in public material. Stated GDPR and CCPA compliance establishes that regimes are addressed and says nothing about where data sits. Compare DeepIP at A for on premise deployment and Solve Intelligence at A for customer selectable jurisdiction. Checked the trust centre material, the home page, the Eureka pages, the Open Platform material and the site navigation on 29 Aug 2026.

Security Certifications and Trust Center

Independent attestation a buyer can pull without a sales call: SOC 2, ISO 27001, penetration test summaries, a trust center with current reports and named scope rather than a badge image.

A published trust centre with named standards and annual audits, held below the top by the type of the SOC report. Published on a dedicated trust centre: certification by the AICPA, ISO 27001:2022 with a statement that systems undergo rigorous annual external audits, encryption using TLS 1.3 and AES-256 in transit and at rest, GDPR and CCPA compliance, and consent management. Naming the ISO revision year and committing to annual external audit addresses currency, which most records on this index omit. THE LIMITING FACT: the SOC attestation is announced and described as SOC 2 Type 1. Type 1 assesses the design of controls at a single point in time; Type 2 tests whether those controls operated effectively across a period. Every other record on this index that reaches A on this axis holds a Type 2 or an equivalent, and the difference is not cosmetic. Held at B on that basis, alongside the absence of a named auditing firm and any certificate date for the ISO. Calibration within this category: Patlytics reaches A on three certifications with named penetration testing partners, and this record publishes a trust centre with a weaker attestation type.

Model Supply Chain Disclosure

Which models sit underneath, whose they are, where they run, and whether the vendor commits to telling customers when that changes. A legal buyer inherits every dependency it cannot see.

Nothing located. No foundation model provider, model family or version is named, and no subprocessor list was found. The vendor describes its architecture in technical terms, naming retrieval augmented generation and what it calls retrieval augmented thinking, and describes domain specific and domain trained models, all of which characterise method rather than provenance. Independent product review notes an evolving AI backbone, which implies underlying models change over time and makes identification more rather than less relevant for a buyer assessing consistency. For a platform whose Open Platform exposes agents to external systems through MCP servers, the identity of the models behind those agents is a question a developer integrating them would ask. Checked the home page, the Eureka pages, the Open Platform material, the trust centre material and independent review material on 29 Aug 2026.

Commercial Transparency

Whether a buyer can learn what this costs without entering a sales process: published rates, the unit being charged, what sits behind an enterprise tier, and what implementation adds.

The pricing structure is disclosed and no figure is. Published through an independent analyst platform and consistent with vendor material: a subscription model with multiple tiers varying by features, user numbers and access levels, with details provided on request based on customer requirements, and a named Enterprise plan that includes specified agents such as the Antibody Target Predictor and Markush Claim Drafting. Knowing that the meter runs on seats and feature tier, and knowing which capabilities sit behind the top tier, tells a buyer how the bill will grow and which plan they would need, which is more structural disclosure than most of this index provides. Two self serve entry points exist and are credited as reducing the barrier: a free trial of Eureka and an API key obtainable from the Open Platform. Held at C because no price, range or entry point figure is published at any level and every commercial route ends in a quote request. Source basis recorded as Third Party Estimated because the tier structure detail comes from an independent analyst listing rather than a vendor pricing page, which was not located.

Firm and Practice Coverage

Who the product is actually built for. AmLaw, midlaw, small firm and solo, in house departments, government and courts, and which practice areas are supported rather than merely claimed.

The largest and most specifically characterised corpus in the category, stated on the dimensions a researcher checks. Scale: more than 2 billion structured data points and over 210 million global patent, science and technology records, spanning patents, scientific literature, litigation records, clinical data and technical knowledge across 20 specialised domains. Breadth beyond patents is the distinguishing element, since prior art is not confined to patents and this is the only record in the category to state coverage of scientific literature and clinical data alongside patent documents. Industry coverage is enumerated across agriculture and chemicals, consumer goods, food and drink, life sciences, automotive, oil and gas, professional services, aviation and aerospace and education. Domain depth is demonstrated rather than claimed in life sciences, with named capability for sequences, Markush structures, structure activity relationship extraction, clinical trial comparison and druggability. Patent translation trained on global patent data addresses cross jurisdiction work directly. Graded A because coverage is enumerated with counts, domains and named artifact types a buyer can test against their own work. Held short of perfection because no update lag or refresh frequency is published and no patent office list is given.